Your session is about to expire
← Back to Search
HIPEC for Adrenocortical Cancer
Study Summary
This trial is looking at the effectiveness of surgery and chemotherapy in treating patients with adrenocortical cancer that has spread to the abdomen.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 3 trial • 256 Patients • NCT01005680Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have severe lung disease with very low lung function test results.I have moderate to severe nerve pain or damage.I do not have major illnesses like heart disease, severe infections, or blood clotting disorders.My white blood cell count is healthy without needing medication.Your platelet count is higher than 75,000 per cubic millimeter.I understand my disease and the experimental treatment combining surgery and HIPEC.Your hemoglobin level is higher than 8.0 grams per deciliter.Your liver blood test results should not show very high levels of AST and ALT, and your total bilirubin should not be too high.I have recovered from previous cancer treatments with minimal side effects.I agree to use birth control during and for four months after chemotherapy.I weigh less than 30 kg.My liver disease is at a moderate to severe stage.You are expected to live for more than three months.Your blood takes a normal amount of time to clot.I can perform daily activities with minimal assistance.I have health issues that make surgery too risky for me.I have a history of heart failure or my heart pumps less effectively.I have or had brain metastases.My scans show that my cancer can be surgically removed.I am 18 years old or older.My disease can be seen on a CT or PET scan.You have severe portal hypertension, which is a condition that affects blood flow in the liver.My cancer is mainly in the belly area and can be surgically removed or treated with a special procedure.My kidney function is normal, with creatinine levels at or below 1.5 mg/dl or clearance above 60 mL/min.
- Group 1: Surgery with HIPEC
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What conditions does Cisplatin usually help manage?
"Cisplatin is an effective treatment against neoplasm metastasis, advanced ovarian cancer, and advanced testicular cancer."
Could I possibly join this clinical trial?
"The eligibility requirements for this clinical trial are that patients must have peritoneal carcinomatosis and be aged 18 to 99. A total of 30 people are needed for the study."
Are there dangerous side effects associated with Cisplatin?
"Cisplatin is a Phase 2 drug, which means that while there are some data supporting its safety, there are no clinical trials demonstrating its efficacy."
Does this research project test subjects of an older age demographic?
"Eligibility for this clinical trial is restricted to patients aged 18 to 99. There are currently 136 studies underway for patients younger than 18 and 3,245 studies being conducted with seniors aged 65 and up."
Are there other scientific papers that mention Cisplatin?
"725 clinical trials are currently studying Cisplatin. 286 of those are Phase 3 trials, which tend to have the most promising data. Though many of these studies originate in Shanghai, there are 43323 locations running them globally."
Are patients currently being accepted into this trial?
"That is correct. The clinical trial, which as of now is looking for 30 participants from 1 site, was updated most recently on March 17th, 2022."
How many people have agreed to take part in this research project?
"According to the clinicaltrials.gov website, this clinical trial is still recruiting patients. The trial was first posted on September 22nd 2017 and was last updated on March 17th 2022. They are currently looking for 30 patients at 1 location."
Share this study with friends
Copy Link
Messenger